The microbicidal potential of visible blue light in clinical medicine and public health.
JournalFrontiers in Medicine
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractVisible blue light of wavelengths in the 400-470 nm range has been observed to have microbicidal properties. A widely accepted hypothesis for the mechanism of microbial inactivation by visible blue light is that the light causes photoexcitation of either endogenous (present within the microbe) or, exogenous (present in the biological medium surrounding the microbe) photosensitizers such as porphyrins and flavins, which leads to the release of reactive oxygen species that subsequently manifests microbicidal activity. Some of the factors that have been observed to be associated with enhanced microbicidal action include increased duration of exposure, and either pre- or co-treatment with quinine hydrochloride. In case of bacteria, repetitive exposure to the blue light shows no significant evidence of resistance development. Additionally, visible blue light has exhibited the ability to inactivate fungal and viral pathogens and, multidrug-resistant bacteria as well as bacterial biofilms. Visible blue light has demonstrated efficacy in eliminating foodborne pathogens found on food surfaces and exposed surfaces in the food processing environment as well as in the decontamination of surfaces in the clinical environment to minimize the spread of nosocomial infections. We conclude from reviewing existing literature on the application of the blue light in clinical medicine and public health settings that this microbicidal light is emerging as a safer alternative to conventional ultraviolet light-based technologies in multiple settings. However, further comprehensive studies and thorough understanding of the mechanism of microbicidal action of this light in different scenarios is warranted to determine its place in human health and disease.
Rights/TermsCopyright © 2022 Haridas and Atreya.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19542
- Visible 405 nm Violet-Blue Light Successfully Inactivates HIV-1 in Human Plasma.
- Authors: Ragupathy V, Haleyurgirisetty M, Dahiya N, Stewart C, Anderson J, MacGregor S, Maclean M, Hewlett I, Atreya C
- Issue date: 2022 Jul 8
- Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms.
- Authors: Halstead FD, Thwaite JE, Burt R, Laws TR, Raguse M, Moeller R, Webber MA, Oppenheim BA
- Issue date: 2016 Jul 1
- Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?
- Authors: Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR
- Issue date: 2012 Aug
- Visible Light as an Antimicrobial Strategy for Inactivation of Pseudomonas fluorescens and Staphylococcus epidermidis Biofilms.
- Authors: Angarano V, Smet C, Akkermans S, Watt C, Chieffi A, Van Impe JFM
- Issue date: 2020 Apr 10
- Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms.
- Authors: Hoenes K, Bauer R, Meurle T, Spellerberg B, Hessling M
- Issue date: 2020